Evidence map›Paper›PMID 42905029›Full record

ArticleJournal of human immunity2026

CRISPR/Cas9-mediated loss of FERMT3 reveals kindlin-3-independent neutrophil activity in LAD-III.

Steven D S Webbers, Felipe Rojas-Rodriguez, Angela A F Gankema, Imran Khan, Judy Geissler, Anton T J Tool, Rupert Öllinger, Robin van Bruggen, Teunis J P van Dam, Suzanna C Fagerholm and 2 more

Abstract read
In one paragraph

Article in Journal of human immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Steven D S Webbers *Department of Research, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID 0000-0003-1064-0776
Felipe Rojas-Rodriguez *Department of Research, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID 0000-0003-2159-7224
Angela A F GankemaDepartment of Research, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID 0000-0001-7073-9677
Imran KhanDepartment of Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-9892-7271
Judy GeisslerDepartment of Research, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID 0000-0002-2645-1008
Anton T J ToolDepartment of Research, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID 0000-0002-8227-1888
Rupert ÖllingerInstitute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich , Munich, Germany.ORCID 0000-0002-2292-5982
Robin van BruggenDepartment of Research, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID 0000-0002-1676-0720
Teunis J P van DamDepartment of Research, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID 0000-0002-8122-190X
Suzanna C FagerholmDepartment of Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-0354-8763
Markus MoserInstitute of Experimental Hematology School of Medicine and Health, Technical University of Munich , Munich, Germany.ORCID 0000-0001-8825-5566
Taco W KuijpersDepartment of Research, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID 0000-0002-7421-3370

Funding

Dutch Ministry of HealthE-Rare-3 326358E-Rare-3 355527E-Rare-3 JTC2018SFSanquin Blood Supply Product and Process Development Cellular Products Fund
6 · The paper itself

Abstract

Mutations in human FERMT3 (encoding kindlin-3 protein) impair β2 integrin activity in neutrophils from patients with leukocyte adhesion deficiency III (LAD-III). Yet kindlin-3's contribution to neutrophil integrin affinity regulation and function remains unclear. Using CD34+ human hematopoietic stem and progenitor cells (HSPCs) differentiated into neutrophils, we investigated how CRISPR/Cas9-mediated kindlin-3 deletion affects neutrophil characteristics. CRISPR/Cas9 targeting FERMT3 resulted in an ∼80-bp deletion within exon 2, impairing protein production. FERMT3 KO neutrophils retained normal in vitro development and phenotype with similar surface marker expression, nuclear morphology, and expansion potential compared with untreated cultured neutrophils. Loss of kindlin-3 abolished zymosan-induced NADPH oxidase activity, recapitulating the ROS production defect of LAD-III neutrophils. However, although basal adhesion was reduced, stimulus-induced integrin activity remained largely intact. FERMT3 KO neutrophils retained fMLP-driven chemotaxis while showing impaired migration in response to C5a. Together, these findings show that disruption of kindlin-3 largely recapitulates the LAD-III phenotype while exerting some effector functions upon stimulation without intact kindlin-3.

Identifiers

PMID42905029
PMCPMC13685712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.